The delisting notice likely makes the entire principal immediately due via cross-default. Monitor for Nasdaq hearing request and any debt restructuring announcement. The restricted cash structure means the company has far less free cash than the headline $22M suggests. Short sellers may target MDCXW given the high probability of delisting and forced liquidation.
Price Chart
Executive Summary
Medicus Pharma entered into a $22M secured note financing with Streeterville Capital, with $12M received upfront and $10M held in a restricted deposit account at Lakeside Bank under a DACA. Simultaneously, the company disclosed receipt of a Nasdaq delisting determination notice, triggering an Event of Default under the notes and creating existential going-concern risk. The delisting risk and punitive loan terms (high prepayment premiums, trigger penalties, restrictive covenants) dominate the filing's impact.
Key Financial Metrics
Key Facts
- Streeterville Capital provided $22M in secured promissory notes: A-1 Note ($12,864,225 principal, 8.75% interest, 18-month maturity) and B Note ($10,000,000 principal, 5% interest, 18-month maturity). Net proceeds to company: $12M after $864K in fees/OID.
- The B Note ($10M) is cash-collateralized in a Lakeside Bank account under a DACA — it is effectively a restricted escrow, not free cash to the company.
- Item 3.01 discloses receipt of a Nasdaq delisting determination notice — this triggers an immediate Event of Default under Section 4.1(n) of the Notes, giving the lender the right to accelerate all ~$22.9M principal plus penalty fees.
- The A-1 Note carries a Trigger Effect allowing the lender to increase the balance by 15% per Major Trigger Event (up to 3 times) and 5% per Minor Trigger Event (up to 3 times), plus prepayment penalties of 110-115%.
- $2.5M of the proceeds were used at closing to repay an existing YA II PN debenture — indicating the company did not receive $22M of fresh capital.
- All subsidiaries (SkinJect, MPI, Antev, MDCX Holdings) provided full asset guarantees, including a lien on all of Antev's key teverelix-TFA patents.
Financial Impact
$22.9M total principal exposure on a ~$19M market cap company. Only $12M was received as unrestricted cash. The $10M B Note is locked in escrow and may only be released via A Note exchanges tied to repayment of the A-1 Note, creating a liquidity trap.
Risk Factors
- Nasdaq delisting would collapse liquidity and make the warrants (MDCXW) nearly worthless.
- Streeterville can trigger default and enforce liens on all subsidiary assets including the teverelix-TFA patent portfolio.
- Restrictive covenants block nearly all alternative financing including variable-rate deals and ATM issuances without Streeterville consent.
- Prepayment penalties (110-115%) make refinancing expensive. Trigger penalties (15% per Major Trigger Event) rapidly inflate the debt balance.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001062993-26-002900 |
| Exhibit: exhibit10-6.htm | 0001062993-26-002900 |
| Exhibit: exhibit10-5.htm | 0001062993-26-002900 |
| Exhibit: exhibit10-4.htm | 0001062993-26-002900 |
| Exhibit: exhibit10-7.htm | 0001062993-26-002900 |
| Exhibit: exhibit10-2.htm | 0001062993-26-002900 |
| Exhibit: exhibit10-3.htm | 0001062993-26-002900 |
| Document: form8k.htm | 0001062993-26-002900 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
May 27, 2026 21w ago | 8-K | $0.6795 $0.6795 | · 0.00% | ▲ +0.32% | — |
Apr 29, 2026 25w ago | 10-K/A | $0.6795 $0.6795 | · 0.00% | ▼ −1.73% | — |
Apr 24, 2026 26w ago | 8-K | $0.6795 $0.6795 | ▲ +0.00% | ▲ +0.40% | — |
Mar 30, 2026 30w ago | EFFECT | $0.6795 $0.6795 | ▲ +0.00% | ▲ +4.30% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers